News events
May 04

The Cancer Research Foundation is pleased to announce that it will field its first ever Chicago Marathon Team.  Currently the team is just one runner strong, but what a contender!  Our inaugural marathon effort will be led by cancer scientist and CRF researcher Samuel Volchenboum, MD, PhD, MS, a children's cancer specialist at the University of Chicago Medical Center.

Sam V runnigDr. Volchenboum was introduced to the Cancer Research Foundation as a Young Investigator Award winner and the value of this award to his work is one of the reasons he's running for the CRF. 

"I think it is important to support organizations like the Cancer Research Foundation. More than anything, it is from groups like this that researchers early in their career can get much-needed support. With an ever-shrinking NIH budget, it is even more critical that foundations continue to support young investigators. With the help of the CRF, I am now in a position to publish and compete for federal dollars. Running the marathon in support of the CRF is just one small thing I can do to give a little back. Please join me out there on October 9, and together we can make a big impact."

Please support Sam's effort by making a donation to the Cancer Research Foundation and indicating on the form that your donation is in honor of Sam's Run. 

We are pleased to be teaming up with the Chicago Area Runner's Association (CARA) which provides running programs to help runners achieve their goals, from beginners to seasoned road warriors.   Sam is participating in CARA's 2011 Summer Marathon Training Program.  To learn more about the Chicago Area Runner's Association click here.

CARA logojoin training button

 

 

 

 

 

Dr. Volchenboum is an expert in pediatric cancers and blood disorders. His specialty is treating children with neuroblastoma, a tumor of the sympathetic nervous system.

In addition to caring for patients, Dr. Volchenboum is studying neuroblastoma in the laboratory, using sophisticated tools to measure the amounts of proteins found in these tumors. He is also pursuing several research projects in biomedical informatics, a field that harnesses tools from the world of computer science to solve complex problems in biology. Dr. Volchenboum has applied informatics techniques to study the genetics of both pediatric and adult cancers, and serves as director of informatics for the Section of Pediatric Hematology/Oncology.

In 2008 Sam was awarded a Cancer Research Foundation Young Investigator Award to study the role of a particular protein in the development of certain high-risk neuroblastimas using the relatively new science of quantitative proteomics.  Proteomics is the study of the composition and function of the proteins that make up the metabolic pathways of our cells. Read more about Sam's work here.

update button